DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,025,149 | +3.3% | 4,132 | 0.0% | 0.11% | +9.7% |
| Q2 2023 | $992,628 | -11.2% | 4,132 | -6.8% | 0.10% | -12.0% |
| Q1 2023 | $1,117,881 | -5.0% | 4,432 | 0.0% | 0.12% | -13.3% |
| Q4 2022 | $1,177,283 | +2.8% | 4,432 | 0.0% | 0.14% | -4.3% |
| Q3 2022 | $1,145,000 | -45.8% | 4,432 | -46.8% | 0.14% | -23.4% |
| Q2 2022 | $2,113,000 | -67.6% | 8,332 | -62.5% | 0.18% | -57.8% |
| Q1 2022 | $6,521,000 | -5.6% | 22,232 | +5.9% | 0.44% | -0.7% |
| Q4 2021 | $6,907,000 | +9.8% | 20,992 | +1.5% | 0.44% | +11.7% |
| Q3 2021 | $6,289,000 | +5.2% | 20,672 | -7.2% | 0.39% | +10.1% |
| Q2 2021 | $5,977,000 | +59.3% | 22,272 | +33.6% | 0.36% | +36.8% |
| Q1 2021 | $3,752,000 | +15.1% | 16,672 | +13.6% | 0.26% | -5.8% |
| Q4 2020 | $3,259,000 | +70.5% | 14,672 | +65.4% | 0.28% | +35.8% |
| Q3 2020 | $1,911,000 | +59.6% | 8,872 | +31.0% | 0.20% | +48.9% |
| Q2 2020 | $1,197,000 | +27.7% | 6,772 | 0.0% | 0.14% | +3.8% |
| Q1 2020 | $937,000 | +22.8% | 6,772 | +36.2% | 0.13% | +45.1% |
| Q4 2019 | $763,000 | -29.4% | 4,972 | -33.6% | 0.09% | -28.9% |
| Q3 2019 | $1,081,000 | +1.0% | 7,486 | 0.0% | 0.13% | -2.3% |
| Q2 2019 | $1,070,000 | +28.9% | 7,486 | +19.1% | 0.13% | +20.2% |
| Q1 2019 | $830,000 | +44.1% | 6,286 | +12.5% | 0.11% | +26.7% |
| Q4 2018 | $576,000 | -5.1% | 5,586 | 0.0% | 0.09% | +19.4% |
| Q3 2018 | $607,000 | -45.0% | 5,586 | -50.1% | 0.07% | -28.0% |
| Q2 2018 | $1,104,000 | +18.8% | 11,186 | +17.9% | 0.10% | +11.1% |
| Q1 2018 | $929,000 | +5.6% | 9,486 | 0.0% | 0.09% | +7.1% |
| Q4 2017 | $880,000 | -13.7% | 9,486 | -20.2% | 0.08% | -7.7% |
| Q3 2017 | $1,020,000 | +1.7% | 11,886 | 0.0% | 0.09% | -1.1% |
| Q2 2017 | $1,003,000 | -1.4% | 11,886 | 0.0% | 0.09% | -3.2% |
| Q1 2017 | $1,017,000 | -62.1% | 11,886 | -65.5% | 0.10% | -30.7% |
| Q4 2016 | $2,684,000 | -21.8% | 34,486 | -21.2% | 0.14% | -18.5% |
| Q3 2016 | $3,432,000 | -36.2% | 43,786 | -17.8% | 0.17% | -29.4% |
| Q2 2016 | $5,382,000 | +6.5% | 53,286 | 0.0% | 0.24% | +0.4% |
| Q1 2016 | $5,055,000 | -14.9% | 53,286 | -16.7% | 0.24% | -15.4% |
| Q4 2015 | $5,943,000 | +17.1% | 63,986 | +7.4% | 0.28% | +4.9% |
| Q3 2015 | $5,077,000 | -0.5% | 59,586 | 0.0% | 0.27% | +6.8% |
| Q2 2015 | $5,100,000 | +0.8% | 59,586 | 0.0% | 0.25% | +0.8% |
| Q1 2015 | $5,059,000 | -4.2% | 59,586 | -3.2% | 0.25% | +0.4% |
| Q4 2014 | $5,279,000 | -22.1% | 61,586 | -30.9% | 0.25% | -3.5% |
| Q3 2014 | $6,776,000 | -3.5% | 89,186 | 0.0% | 0.26% | +1.6% |
| Q2 2014 | $7,022,000 | +5.0% | 89,186 | 0.0% | 0.25% | +0.4% |
| Q1 2014 | $6,689,000 | – | 89,186 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |